BR112019009246A2 - formulações de cosméticos para aplicações tópicas contendo moléculas derivadas de eritropoietina - Google Patents

formulações de cosméticos para aplicações tópicas contendo moléculas derivadas de eritropoietina

Info

Publication number
BR112019009246A2
BR112019009246A2 BR112019009246A BR112019009246A BR112019009246A2 BR 112019009246 A2 BR112019009246 A2 BR 112019009246A2 BR 112019009246 A BR112019009246 A BR 112019009246A BR 112019009246 A BR112019009246 A BR 112019009246A BR 112019009246 A2 BR112019009246 A2 BR 112019009246A2
Authority
BR
Brazil
Prior art keywords
derived
cosmetic formulations
topical applications
derived molecules
applications containing
Prior art date
Application number
BR112019009246A
Other languages
English (en)
Other versions
BR112019009246B1 (pt
Inventor
Bader Augustinus
Original Assignee
Asc Regenity Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asc Regenity Ltd filed Critical Asc Regenity Ltd
Publication of BR112019009246A2 publication Critical patent/BR112019009246A2/pt
Publication of BR112019009246B1 publication Critical patent/BR112019009246B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

a presente invenção refere-se a formulação de cosméticos, e entidades relacionadas ao novo peptídeo, projetadas para o tratamento cosmético da pele de ser humano. em mais detalhes, a invenção é relacionada aos peptídeos que alvejam células cd90 de tecido positivo, e corresponde ou são derivados de sequência parcial de eritropoietina (epo), mas não induzem substancialmente um tecido hematopoiético de efeito regenerador e protetor. em particular, a invenção divulga peptídeos protetores de tecidos derivados de epo, em relação funcional à estrutura de lipídeos, e agentes que desencadeiam um relaxamento da vasculatura, e promovem o transporte transdérmico das entidades de polipeptídeo para as células da pele alvejadas.
BR112019009246-3A 2016-11-10 2017-11-07 Formulações cosméticas contendo moléculas derivadas de eritropoietina, polipeptídeo isolado e uso do mesmo BR112019009246B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16002375.0 2016-11-10
EP16002375 2016-11-10
PCT/EP2017/001289 WO2018086732A1 (en) 2016-11-10 2017-11-07 Cosmetic formulations for topical applications containing erythropoietin-derived molecules

Publications (2)

Publication Number Publication Date
BR112019009246A2 true BR112019009246A2 (pt) 2019-07-16
BR112019009246B1 BR112019009246B1 (pt) 2023-01-17

Family

ID=57288099

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019009246-3A BR112019009246B1 (pt) 2016-11-10 2017-11-07 Formulações cosméticas contendo moléculas derivadas de eritropoietina, polipeptídeo isolado e uso do mesmo

Country Status (11)

Country Link
US (2) US10456346B2 (pt)
EP (1) EP3538065B1 (pt)
JP (1) JP7167019B2 (pt)
KR (1) KR102499651B1 (pt)
CN (1) CN110234311B (pt)
AU (1) AU2017357374B2 (pt)
BR (1) BR112019009246B1 (pt)
CA (1) CA3042295A1 (pt)
ES (1) ES2952448T3 (pt)
PL (1) PL3538065T3 (pt)
WO (1) WO2018086732A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4093369A1 (en) 2020-01-21 2022-11-30 ASC Regenity Ltd. Cosmetic formulation for topical administration comprising novel peptides that improve appearance and regeneration of skin

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175333A1 (en) 2002-03-06 2003-09-18 Adi Shefer Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin
EP1517988B1 (de) 2002-06-20 2013-05-08 Augustinus Bader Verwendung von Erythropoietin zur Geweberegeneration in vivo
ES2606068T3 (es) 2003-12-30 2017-03-17 Augustinus Bader Eritropoyetina para uso en el tratamiento de heridas o el trasplante de células
UA100222C2 (uk) 2005-08-05 2012-12-10 Араім Фармасьютікалз, Інк. Тканинозахисні пептиди і їх застосування
US20110123481A1 (en) * 2007-08-16 2011-05-26 Remedor Biomed Ltd. Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
CN101951944B (zh) 2007-12-28 2015-04-01 奥古斯蒂努斯·巴德 用于皮肤创伤愈合的红细胞生成素的局部施用和配制剂
SG10201604530SA (en) * 2008-01-22 2016-07-28 Araim Pharmaceuticals Inc Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
DK2590666T3 (en) * 2010-07-06 2017-07-17 Augustinus Bader TOPICAL APPLICATION OF ERYTHROPOIETIN FOR USE IN THE TREATMENT OF DAMAGE OF THE CORNS
BR112013008173A2 (pt) 2010-10-04 2017-12-05 Cupron Inc composições cosméticas para o cuidado com a pele
US20120189674A1 (en) * 2011-01-24 2012-07-26 Kale Kalidas M Compositions for topical delivery of the pharmacologically active compounds
CN102205114B (zh) * 2011-04-29 2012-12-12 中国人民解放军第三军医大学 促红细胞生成素来源肽在制备治疗神经系统自身免疫性疾病的药物中的应用
KR20150130616A (ko) 2014-05-13 2015-11-24 (주)케어젠 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도

Also Published As

Publication number Publication date
CA3042295A1 (en) 2018-05-17
WO2018086732A1 (en) 2018-05-17
EP3538065B1 (en) 2023-08-02
BR112019009246B1 (pt) 2023-01-17
AU2017357374A1 (en) 2019-05-02
EP3538065C0 (en) 2023-08-02
US20190254948A1 (en) 2019-08-22
ES2952448T3 (es) 2023-10-31
EP3538065A1 (en) 2019-09-18
AU2017357374B2 (en) 2023-05-18
PL3538065T3 (pl) 2023-12-04
KR102499651B1 (ko) 2023-02-13
KR20190083658A (ko) 2019-07-12
US10456346B2 (en) 2019-10-29
JP2019533712A (ja) 2019-11-21
JP7167019B2 (ja) 2022-11-08
CN110234311A (zh) 2019-09-13
US11197812B2 (en) 2021-12-14
CN110234311B (zh) 2022-08-12
US20200009037A1 (en) 2020-01-09

Similar Documents

Publication Publication Date Title
BR112017007892A2 (pt) composição, e, preparação injetável.
BR112018073699A2 (pt) amino lipídios de sulfonamida catiônica e amino lipídios zwiteriônico anfifílicos
WO2016090145A8 (en) Exfoliating cosmetic compositions
BR112017023380A2 (pt) sistema, composição cosmética, métodos para tratamento de substratos queratinosos e para proteção e/ou alisamento da fibra do cabelo, kit multicompartimento, e, processo para alisamento do cabelo.
BR112015026258A2 (pt) composições e agentes terapêuticos e imunomoduladores, e usos dos mesmos
BR112014004859A2 (pt) preparação e composições de enxofre zerovalente altamente biodisponíveis e usos das mesmas
CO7010783A2 (es) Proteína naglu humana recombinante y usos de la misma
CU23734A1 (es) Polipéptidos inmunomoduladores derivados de la il-2 con actividad antagonista de esta citocina útiles en la terapia del cáncer y enfermedades infecciosas crónicas
BR112016027871A2 (pt) composição para melhorar a memória, a função de aprendizado e/ou função cognitiva
CL2021000207A1 (es) Nuevas proteínas de fusión específicas para cd137 y pd-l1
BR112021015751A2 (pt) Vetores de terapia genética para tratamento da doença de danon
MY191980A (en) Formulations containing an extract of echinacea and linoleic acid derivatives
BR112015021124A2 (pt) solução para acne
BR112017019358A2 (pt) combinações e formulações de dose fixa compreendendo etc1002 e ezetimiba e métodos de tratamento ou redução do risco de doença cardiovascular
BR112016001919A2 (pt) composição cosmética e processo de tratamento cosmético
BR112015029815A2 (pt) composição cosmética para clarear uma pele e/ou cabelo de um indivíduo, conjunto para clarear uma pele e/ou um cabelo de um individuo, método cosmético para clarear uma pele e/ou um cabelo de um individuo, composição cosmética ou farmacêutica para aplicação na pele, cabelo e/ou unha de um indivíduo, conjunto para aplicar uma composição cosmética ou farmacêutica na pele cabelo e/ou unha de um individuo e método de administração de peróxido de hidrogênio na pele, cabelo e/ou unha de indivíduo.
AR117730A1 (es) Composición para relajación muscular
BR112017018209A2 (pt) produtos terapêuticos de polipeptídeo e usos dos mesmos
BR112023020245A2 (pt) Composição, métodos para estimular o crescimento do cabelo e para promover o crescimento do cabelo, kit e uso de uma composição
BR112018073862A2 (pt) composição para cuidado dos cabelos
BR112015023793A2 (pt) composições e métodos de terapias para indução de tolerância imune a substituição do fator vii em indivíduos com hemofilia a
PH12018500910A1 (en) Novel method of use and compositions
BR112015019568A2 (pt) Peptídeo isolado, composição compreendendo o mesmo e uso do mesmo
BR112019009246A2 (pt) formulações de cosméticos para aplicações tópicas contendo moléculas derivadas de eritropoietina
PH12017501756A1 (en) Natural-substance combination containing at least one glycyrrhetinic acid and at least one guggelsterone and use thereof for cosmetic applications

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/11/2017, OBSERVADAS AS CONDICOES LEGAIS